Health Canada has approved Moderna's mRNA vaccine to protect against respiratory syncytial virus in adults age 60 and older, ...

GSK’s Arexvy has received expanded approval in Canada for preventing RSV-related lower respiratory tract disease in adults ...

Pfizer gave little information ... this morning that Arexvy had helped the group deliver an “excellent performance” in 2023, adding that it is planning at least 12 major product launches ...

ZORYVE is uniquely formulated as an emollient, water-based product without fragrances or penetration enhancers ... and pediatric patients 6 years of age and older. IMPORTANT SAFETY INFORMATION ZORYVE ...

Health Canada has approved the vaccine, mRESVIA, for the prevention of lower respiratory tract disease in older adults, the company said.

The ROS1 inhibitor market for NSCLC, valued at around $290 million in 2023 across the USA, Europe, and Japan, is set for growth with new-generation therapies targeting resistance mutations.

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei ... also call upon it to help it distribute new shot Arexvy. Herpes zoster vaccine Shingrix for shingles has ...

Nov. 7, 2024 — A less wasteful way to train large language models, such as the GPT series, finishes in the same amount of time for up to 30% less energy, according to a ... Flagship AI-Ready ...

The Professional Certificate in Product Management is for those who want to build on or formalize their training for product management roles, including: Early-career professionals with one to five ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent ... a GlobalData owned brand. The ...

Natural products are small molecules produced naturally by any organism including primary and secondary metabolites. They include very small molecules, such as urea, and complex structures ...

The newly approved vaccine, known as Arexvy, represents an advance in preventive health measures, addressing a significant adult demographic at risk from RSV complications. With this approval, Canada ...